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TEMPORAL ASPECTS OF DNA RE-
PAIR PROCESSES AFTER DRUGS
AND RADIATION. B. W. Fox, Paterson
Laboratories, Christie Hospital and Holt
Radium Institute, M4nchester.
Before considering the ultimate effect of
drug and radiation in combination on
biological end points such as cell cycle phase
parameter changes, mutation frequency and
eventually survival, it is desirable to know
what sequence of changes may be expected
following the drug or radiation treatment
alone. The timing of events within the cell
attempting to overcome damage to its DNA
will depend on (a) the nature and multiplicity
of the lesions produced on the DNA, (b) the
genetic competence of the cell to undertake
the different types of repair required by such
lesions, (c) the conditions under which the cell
is growing which may favour or hinder
different repair mechanisms and (d) the
efficiency ofeach repair event in restoring the
full competence of the original DNA in its
transcriptional and replicative roles. Diffi-
culties experienced during these events may
determine the subsequent fate of the cell.
These difficulties result from a subtle inter-
play of dose-time relationships of the
characteristic biochemical disturbances
exerted by each agent. An attempt has been
made to understand the interplay of some of
these events using alkylating agents such as
methyl methane sulphonate and methyl-
nitro-nitrosoguanidine and comparing them
with both x-rays and ionizing radiation.
The present status ofsuch studies designed to
rationalize combination treatment could not
be considered to do more than influence to a
small extent an otherwise empirical approach
to combination treatment.
EFFECTS OF DAUNOMYCIN, BLEO-
MYCIN, CYTOSINE ARABINOSIDE,
ACRONYCINE AND IONIZING
RADIATION ON THE CELL CYCLE
IN VITRO AND IN VIVO. W. A. LINDEN,
S. B. REDDY and F. ZYWIETZ, Institut fur
Biophysik und Strahlenbiologie der Univer-
sitait Hamburg.
Four chemotherapeutic agents without, or
in combination with, 200 kV x-rays were
examined for their influence on cell cycle
progression and viability of mouse L-cells.
The action of daunomycin and ionizing
radiation was also tested on the Walker
carcinoma in vivo. The cell kinetics after
different treatments were studied using the
technique of pulse cytophotometry. By this
method, DNA distribution patterns (DNA
histograms) of the cells were obtained. The
mathematical analysis of the DNA histo-
grams yields the fractions ofcells in G1, S and
G2 or M. Cytosine arabinoside predomi-
nantly blocked the cells in S phase while
daunomycin, bleomycin and acronycine ac-
cumulated the cells in (G2 + M)-phase.
These results vary in combination with
irradiation.
EFFECTS OF INTERACTIONS OF
CELL CYCLE-SPECIFIC CYTOTOXIC
DRUGS AND X-RADIATION ON
SURVIVAL OF CELL REPRODUCTIVE
CAPACITY. R. J. BERRY, MRC Radio-
biology Unit, Harwell.
Cells of murine leukaemia P-388 in vivo
and HeLa cells in vitro have been used for
several years to study interactions between
effects of cytotoxic chemotherapeutic agents,
including halopyrimidines and folic acid
antagonists, and subsequent survival of cell
reproductive capacity after x-irradiation.
Using these latter classes of drugs as specific
examples, combination of information on
drug radiation interactions with even our
limitedknowledge ofcellproliferationkinetics
in tumours and dose limiting normal tissues
allows some predictions to be made about
effects of the sequential and concomitant use
of cytotoxic drugs with conventional and
unorthodox dose fractionation in radio-
therapy.
EFFECTIVENESS OF COMBINED
TREATMENTS OF VARIOUS TYPES
OF TRANSPLANTABLE RAT
TUMOUR WITH IONIZING RADIA-
TION AND DRUGS. G. W. BARENDSEN,
A. F. HERMENS and H. C. JANSE, Radio-
biological Institute TNO, Rijswijk.
Many tumours in animals and man
contain, in addition to proliferating (P) cells,